Psigryph Inc.

Startup
Summarized by Halo AI

Psigryph Inc. is a Canadian biotech firm that developed Nanopect™, a patented, plant-derived nanodelivery platform. It increases the bioavailability of bioactive molecules for applications in pharmaceuticals, agriculture, and nutrition.

Founded & HQ
Guelph, ON, Canada
Company size
1-10 employees
Funding
~$99.9K
IP status
18 patents filed · 2 grants confirmed
Activity highlights
Accepted into the MassChallenge Switzerland Accelerator cohort and HudsonAlpha AgTech Accelerator powered by genter8tor. Awarded $300,000 grant funding by Intellectual Property Ontario and received a $100,000 investment by the HudsonAlpha AgTech Fund II. Dietary supplement, Cholestello launched online in the USA at www.cholestello.com.

Psigryph Inc. is a foodtech and agritech company founded in 2018, focused on developing biodegradable nanotechnology solutions to improve the delivery of bioactive molecules across cell membranes, with applications in health, agriculture, and environmental sustainability.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

ST
Sean Thompson
Co-Founder & CEO
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Sponsored researchCo-developmentLicensingEquity investmentPilot or trial engagement
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.